James Lind

James Lind (4 October 1716 – 13 July 1794) was a Scottish physician and a pioneer of naval hygiene in the Royal Navy. He is best known for his work in the prevention of scurvy.
Early Life and Education[edit]
James Lind was born in Edinburgh, Scotland, on 4 October 1716. He studied medicine at the University of Edinburgh, where he graduated with an MD in 1748.
[edit]
Lind joined the Royal Navy in 1739 as a surgeon's mate. During his service, he observed the poor health conditions of sailors, particularly the prevalence of scurvy, a disease caused by a deficiency of vitamin C.
Scurvy Experiment[edit]
In 1747, while serving on the HMS Salisbury, Lind conducted one of the first clinical trials in history. He selected 12 sailors suffering from scurvy and divided them into six groups, each receiving different treatments. The group that received oranges and lemons showed remarkable improvement, leading Lind to conclude that citrus fruits were effective in preventing and treating scurvy.
Publication of Findings[edit]
In 1753, Lind published his findings in a treatise titled A Treatise of the Scurvy. Despite the evidence, it took several decades for the British Admiralty to implement his recommendations. By the late 18th century, the inclusion of lemon juice in sailors' diets became standard practice, significantly reducing the incidence of scurvy.
Later Life and Legacy[edit]
After retiring from the navy, Lind continued his medical practice and research. He was appointed as the chief physician of the Royal Naval Hospital at Haslar in 1758. Lind's work laid the foundation for modern clinical trials and significantly improved the health and efficiency of naval personnel.
James Lind died on 13 July 1794 in Gosport, Hampshire, England.
See Also[edit]
References[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian